Vitruvian Partners LLP reduced its position in Xometry, Inc. (NASDAQ:XMTR - Free Report) by 25.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 266,285 shares of the company's stock after selling 93,200 shares during the quarter. Xometry makes up approximately 9.8% of Vitruvian Partners LLP's portfolio, making the stock its 4th biggest position. Vitruvian Partners LLP owned 0.54% of Xometry worth $11,360,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also made changes to their positions in the business. Barclays PLC raised its holdings in Xometry by 360.9% in the third quarter. Barclays PLC now owns 68,951 shares of the company's stock valued at $1,266,000 after acquiring an additional 53,991 shares in the last quarter. Weiss Asset Management LP purchased a new stake in shares of Xometry during the 3rd quarter worth $1,586,000. Connor Clark & Lunn Investment Management Ltd. purchased a new position in Xometry in the third quarter valued at $355,000. Charles Schwab Investment Management Inc. increased its holdings in Xometry by 4.8% in the third quarter. Charles Schwab Investment Management Inc. now owns 354,849 shares of the company's stock valued at $6,519,000 after buying an additional 16,396 shares during the last quarter. Finally, Centiva Capital LP acquired a new stake in Xometry in the third quarter valued at $341,000. Hedge funds and other institutional investors own 97.31% of the company's stock.
Insiders Place Their Bets
In related news, CFO James Miln sold 5,386 shares of the company's stock in a transaction that occurred on Friday, January 3rd. The stock was sold at an average price of $42.33, for a total value of $227,989.38. Following the sale, the chief financial officer now owns 102,329 shares in the company, valued at $4,331,586.57. This represents a 5.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, COO Peter Goguen sold 940 shares of Xometry stock in a transaction on Friday, January 3rd. The stock was sold at an average price of $42.36, for a total value of $39,818.40. Following the transaction, the chief operating officer now directly owns 167,993 shares of the company's stock, valued at approximately $7,116,183.48. This represents a 0.56 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 73,965 shares of company stock worth $2,050,643. Company insiders own 16.79% of the company's stock.
Analyst Upgrades and Downgrades
XMTR has been the subject of several recent analyst reports. Cantor Fitzgerald boosted their target price on Xometry from $12.00 to $20.00 and gave the stock an "underweight" rating in a research note on Wednesday, February 26th. JMP Securities restated a "market outperform" rating and issued a $42.00 target price on shares of Xometry in a report on Monday, February 10th. Wedbush reiterated an "outperform" rating and set a $48.00 price target on shares of Xometry in a research note on Friday, December 20th. JPMorgan Chase & Co. upgraded shares of Xometry from a "neutral" rating to an "overweight" rating and upped their price objective for the company from $25.00 to $45.00 in a research note on Wednesday, December 18th. Finally, Royal Bank of Canada boosted their target price on Xometry from $27.00 to $40.00 and gave the company a "sector perform" rating in a report on Friday, January 3rd. One analyst has rated the stock with a sell rating, two have issued a hold rating and six have assigned a buy rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $36.11.
Read Our Latest Stock Analysis on XMTR
Xometry Stock Performance
Shares of XMTR stock traded down $0.71 during mid-day trading on Wednesday, hitting $26.11. The stock had a trading volume of 129,056 shares, compared to its average volume of 595,612. The firm has a market cap of $1.31 billion, a PE ratio of -24.89 and a beta of 0.69. The company's 50-day simple moving average is $30.99 and its 200-day simple moving average is $28.95. The company has a debt-to-equity ratio of 0.90, a current ratio of 4.59 and a quick ratio of 4.55. Xometry, Inc. has a fifty-two week low of $11.08 and a fifty-two week high of $45.33.
About Xometry
(
Free Report)
Xometry, Inc operates an online marketplace that enables buyers to source custom-manufactured parts and assemblies in the United States and internationally. It provides computer numerical control manufacturing, sheet metal forming, and sheet cutting; 3D printing, including fused deposition modeling, direct metal laser sintering, PolyJet, stereolithography, selective laser sintering, binder jetting, carbon digital light synthesis, multi jet fusion, and lubricant sublayer photo-curing; and die casting, stamping, injection molding, urethane casting, tube cutting, and tube bending, as well as finishing services, rapid prototyping, and high-volume production services.
See Also
Before you consider Xometry, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xometry wasn't on the list.
While Xometry currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
